ArticleJournal of managed care & specialty pharmacy2024

Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019.

Angela Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.